[01Booster] Taking the opportunity of Meiji Accelerator to
collaborate. THE PHAGE raises funds in pre-series A round
*01Booster*
Press release: September 12, 2024
**
Taking Meiji Accelerator as an opportunity to collaborate. THE PHAGE raises funds in pre-series A round
*A startup that promotes data health and medical DX through AI development in the health and medical field. Announcement of collaboration with Meiji to explore the potential of various health values in food*
Zero One Booster Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo, Representative Director: George Goda,
01Booster) held “Meiji Accelerator 2022” together with Meiji Co., Ltd. (President: Katsuya Matsuda, hereinafter “Meiji”).
The Phage (Headquarters: Shibuya-ku, Tokyo, Representative Director and CEO: Shohei Tokunaga, hereinafter referred to as “THE”) is a startup selected for this program.
PHAGE” has completed its pre-series A round of funding. In addition to additional funding from Genesia Ventures, the lead investor from the company’s seed round, new investors Vision Incubate, KSP, and Co., Ltd.
We also raised funds from Meiji (Meiji), TOPPAN Holdings Co., Ltd. (TOPPAN), Mizuho Capital Co., Ltd., Mirai Soso Capital Co., Ltd., and Mediva Co., Ltd.
Also, THE
PHAGE has agreed to a strategic business partnership with TOPPAN to support the research and development of foods with health claims. Furthermore, we will continue to collaborate with Meiji to explore the potential of various health values in foods.
Meiji Accelerator website: https://01booster.com/program/meiji/
*What is Meiji Accelerator*
This is an open innovation program that seeks partners to co-create in the areas of “food,” “physical and mental health,” “sustainability,” and “digital technology,” aiming for a healthy future for people and the planet. By combining the wisdom and value chain cultivated by the 100-year-old Meiji Group with new technology and various ideas, we worked with 12 selected Meiji employee catalysts to create value that is one step ahead. To date, two terms (2021 and 2022) have been implemented.
https://01booster.com/program/meiji/
* Background and purpose of funding *
THE
PHAGE is a startup that introduces new medical and healthcare experiences to society by analyzing the relationship between daily biological information and lifestyle behaviors and making proposals that are individually optimized for each person.
While a huge variety of biological information exists, the company first focused on blood sugar levels, which respond most sensitively to daily activities such as eating and exercise. Blood sugar levels change dynamically and due to multiple factors, and until now it has been difficult to analyze them unless you are a medical professional. For this reason, the company has been exploring ways to utilize blood sugar levels in daily life through multiple R&D and demonstration experiments.
Through this funding, the company will support research and
development in the medical and healthcare fields, including food, medical care, and insurance, as well as a diabetes treatment business that utilizes AI in the health and medical field, which requires high ethical standards and quality control. We will develop it as a business and move to a format that can be operated on a commercial basis on a large scale and on a daily basis.
In the future, in addition to advancing the operations of existing businesses as quickly as possible, it will be essential to integrate the knowledge of diverse experts in order to strengthen the system. We are looking forward to the participation of professionals who support the promotion of data health and medical DX through AI development in the health and medical field.
* ・Currently recruiting positions*
Data Scientist
Web Engineer
Mobile Engineer
Product Manager
UI/UX Designer
Market Access
Clinical Affairs
Doctor (Medical Affairs)
Registered Dietitian
Sales staff for administrative and local governments in the insurance and medical fields
Management department person (Back Office)
*View details*
* About diabetes medical support service “Glucose Flight (R)” * “Glucose Flight (R)” is a general medical treatment support service for diabetes that provides personalized lifestyle suggestions. By analyzing individual biological information and proposing individually optimized lifestyle behaviors, we promote users’ independent blood sugar management, and provide healthcare professionals with accurate advice tailored to patients’ lifestyles and dietary styles. Support nutritional guidance.
*To use the patient app, you will need a user ID given by your medical institution.
Currently, THE PHAGE is providing Glucose Flight (R) on a limited basis to some hospitals and clinics.
If you are a medical institution such as a hospital or clinic and are interested, please contact the company.
App name: “Glucose Flight (R)”
Compatible devices: iPhone (iOS) App Store
*THE PHAGE representative comment*
*The Phage Co., Ltd. Representative Director and CEO Shohei Tokunaga* Thanks to the help of all our investors, we were able to successfully complete our fundraising. I would like to express my sincere gratitude for the opportunity to take on the challenge of “promoting data health and medical DX through AI development in the health and medical field,” a new field that is rapidly growing with the recent evolution of AI and wearables.
In this round, we are looking forward to meeting not only new shareholders but also new colleagues as we move forward with social implementation.
Company name: THE PHAGE, Inc.
Representative: Shohei Tokunaga
Established: July 15, 2021
Location: 5th floor, Yamaguchi Building, 3-17-4 Shibuya, Shibuya-ku, Tokyo Business content: Medical and healthcare product development/R&D support URL: https://thephage.life/
Zero One Booster Co., Ltd.
Based on our corporate philosophy of “Changing the world through the power of business creation,” we have established an open innovation program that promotes collaboration between major companies and venture companies, a system to promote in-house new business, an open recruitment new business program, and a secondment system. We are developing business development programs, etc. In addition, Yurakucho “SAAI” Wonder is a working community that gives form to individual ideas.
01Booster, which supports the operation of “Working Community” and startups from scratch.
Studio, and startup collaboration management cloud InnoScouter. We also make venture investments through our group company 01Booster Capital, and support business creation from multiple angles. Trade name: Zero One Booster Co., Ltd.
Representative: Representative Director George Goda
Address: 1st floor, Shin-Tokyo Building, 3-3-1 Marunouchi, Chiyoda-ku, Tokyo 100-0005
Established: March 2012
Business details:
Shared offices for entrepreneurs, planning and operation of corporate accelerator/intrapreneur accelerator programs, training for corporate entrepreneurs, investment and financing support, business creation consulting, M&A intermediary support, etc.
URL: https://01booster.co.jp
*Corporate Accelerator is a registered trademark of 01Booster.